Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of aspergillus infections

40Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Voriconazole is the preferred antifungal agent for Aspergillus infections. Therapeutic drug monitoring is recommended to achieve target concentrations and prevent toxicity. However, variable pharmacokinetics, cytochrome P450 polymorphisms, and extensive drug-drug interactions can contribute to subtherapeutic concentrations. We report a voriconazole "boosting" effect of omeprazole to achieve target concentrations for the treatment of Aspergillus in a patient who had persistently subtherapeutic trough concentrations. Copyright © 2012, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Boyd, N. K., Zoellner, C. L., Swancutt, M. A., & Bhavan, K. P. (2012). Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of aspergillus infections. Antimicrobial Agents and Chemotherapy, 56(11), 6001–6002. https://doi.org/10.1128/AAC.00700-12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free